Cite
Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy.
MLA
Şimşir, Ilgın Yıldırım, et al. “Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy.” Endocrinology Research & Practice, vol. 28, no. 3, July 2024, pp. 181–83. EBSCOhost, https://doi.org/10.5152/erp.2024.24414.
APA
Şimşir, I. Y., Özgür, S., Soyaltın, U. E., & Çetinkalp, Ş. (2024). Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy. Endocrinology Research & Practice, 28(3), 181–183. https://doi.org/10.5152/erp.2024.24414
Chicago
Şimşir, Ilgın Yıldırım, Su Özgür, Utku Erdem Soyaltın, and Şevki Çetinkalp. 2024. “Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy.” Endocrinology Research & Practice 28 (3): 181–83. doi:10.5152/erp.2024.24414.